iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial

被引：43

作者：

Baksaas-Aasen, Kjersti ^{[1
]}

Gall, Lewis ^{[2
]}

Eaglestone, Simon ^{[2
]}

Rourke, Claire ^{[2
]}

Juffermans, Nicole. P. ^{[3
]}

Goslings, J. Carel ^{[4
]}

Naess, Paal Aksel ^{[1
]}

van Dieren, Susan ^{[4
]}

Ostrowski, Sisse Rye ^{[8
]}

Stensballe, Jakob ^{[8
]}

Maegele, Marc ^{[5
]}

Stanworth, Simon J. ^{[6
,7
]}

Gaarder, Christine ^{[1
]}

Brohi, Karim ^{[2
]}

Johansson, Per I. ^{[8
]}

机构：

[1] Oslo Univ Hosp, Dept Traumatol, Oslo, Norway

[2] Queen Mary Univ London, Blizard Inst, Ctr Trauma Sci, London, England

[3] Acad Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands

[4] Acad Med Ctr, Dept Surg, Trauma Unit, Amsterdam, Netherlands

[5] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Traumatol & Orthoped Surg, Cologne, Germany

[6] NHS Blood & Transplant Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Oxford, England

[7] Univ Oxford, Radcliffe Dept Med, Oxford, England

[8] Copenhagen Univ Hosp, Sect Transfus Med, Capital Reg Blood Bank, Rigshosp, Copenhagen, Denmark

来源：

TRIALS | 2017年 / 18卷

关键词：

Trauma; Haemorrhage; Trauma-induced coagulopathy; Viscoelastic haemostatic assays; Randomised control trial; Conventional coagulation tests; Transfusion; HEMOSTATIC RESUSCITATION; MORTALITY; TRANSFUSION; DEFINITION; PRODUCTS; PLASMA; RATIO;

D O I：

10.1186/s13063-017-2224-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background: Traumatic injury is the fourth leading cause of death globally. Half of all trauma deaths are due to bleeding and most of these will occur within 6 h of injury. Haemorrhagic shock following injury has been shown to induce a clotting dysfunction within minutes, and this early trauma-induced coagulopathy (TIC) may exacerbate bleeding and is associated with higher mortality and morbidity. In spite of improved resuscitation strategies over the last decade, current transfusion therapy still fails to correct TIC during ongoing haemorrhage and evidence for the optimal management of bleeding trauma patients is lacking. Recent publications describe increasing the use of Viscoelastic Haemostatic Assays (VHAs) in trauma haemorrhage; however, there is insufficient evidence to support their superiority to conventional coagulation tests (CCTs). Methods/design: This multicentre, randomised controlled study will compare the haemostatic effect of an evidence-based VHA-guided versus an optimised CCT-guided transfusion algorithm in haemorrhaging trauma patients. A total of 392 adult trauma patients will be enrolled at major trauma centres. Participants will be eligible if they present with clinical signs of haemorrhagic shock, activate the local massive haemorrhage protocol and initiate first blood transfusion. Enrolled patients will be block randomised per centre to either VHA-guided or CCT-guided transfusion therapy in addition to that therapy delivered as part of standard care, until haemostasis is achieved. Patients will be followed until discharge or 28 days. The primary endpoint is the proportion of subjects alive and free of massive transfusion (less than 10 units of red blood cells) at 24 h. Secondary outcomes include the effect of CCT-versus VHA-guided therapy on organ failure, total hospital and intensive care lengths of stay, health care resources needed and mortality. Surviving patients will be asked to complete a quality of life questionnaire (EuroQol EQ-5D (TM)) at day 90. Discussion: CCTs have traditionally been used to detect TIC and monitor response to treatment in traumatic major haemorrhage. The use of VHAs is increasing, but limited evidence exists to support the superiority of these technologies (or comparatively) for patient-centred outcomes. This knowledge gap will be addressed by this trial.

引用

页数：13

共 29 条

[1] Thromboelastography and Rotational Thromboelastometry use in trauma [J].